PL3191099T3 - Pochodne pirydopirymidyn - Google Patents

Pochodne pirydopirymidyn

Info

Publication number
PL3191099T3
PL3191099T3 PL15840871T PL15840871T PL3191099T3 PL 3191099 T3 PL3191099 T3 PL 3191099T3 PL 15840871 T PL15840871 T PL 15840871T PL 15840871 T PL15840871 T PL 15840871T PL 3191099 T3 PL3191099 T3 PL 3191099T3
Authority
PL
Poland
Prior art keywords
pyridopyrimidines
derivatives
Prior art date
Application number
PL15840871T
Other languages
English (en)
Inventor
Gilberto De Nucci
Original Assignee
Biolab Sanus Farmacéutica Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biolab Sanus Farmacéutica Ltda filed Critical Biolab Sanus Farmacéutica Ltda
Publication of PL3191099T3 publication Critical patent/PL3191099T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL15840871T 2014-09-12 2015-09-11 Pochodne pirydopirymidyn PL3191099T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462049506P 2014-09-12 2014-09-12
EP15840871.6A EP3191099B1 (en) 2014-09-12 2015-09-11 Derivatives of pyridopyrimidines
PCT/BR2015/050147 WO2016037255A2 (en) 2014-09-12 2015-09-11 New pyridopyrimidines derivatives compounds

Publications (1)

Publication Number Publication Date
PL3191099T3 true PL3191099T3 (pl) 2019-07-31

Family

ID=55454107

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15840871T PL3191099T3 (pl) 2014-09-12 2015-09-11 Pochodne pirydopirymidyn

Country Status (18)

Country Link
US (2) US10280162B2 (pl)
EP (1) EP3191099B1 (pl)
JP (1) JP6661606B2 (pl)
KR (1) KR20170054408A (pl)
CN (2) CN107074847A (pl)
AR (1) AR101813A1 (pl)
AU (1) AU2015316120B2 (pl)
BR (1) BR112017004919A2 (pl)
CA (1) CA2958331C (pl)
CL (1) CL2017000582A1 (pl)
CO (1) CO2017001709A2 (pl)
ES (1) ES2701273T3 (pl)
HU (1) HUE040387T2 (pl)
IL (1) IL250968B (pl)
MX (1) MX2017003067A (pl)
PL (1) PL3191099T3 (pl)
PT (1) PT3191099T (pl)
WO (1) WO2016037255A2 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3189070A4 (en) 2014-08-04 2018-06-27 Drexel University Novel compounds and methods of treating or ameliorating an il-1r-mediated disease or disorder using same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002000657A2 (en) * 2000-06-26 2002-01-03 Lilly Icos Llc Condensed pyrazindione derivatives
CA2420286A1 (en) 2000-08-31 2002-03-07 F. Hoffmann-La Roche Ag 7-oxo pyridopyrimidines as inhibitors of a cellular proliferation
WO2002038563A2 (en) * 2000-11-08 2002-05-16 Lilly Icos Llc Condensed pyrazindione derivatives as pde inhibitors
FR2896246B1 (fr) * 2006-01-13 2008-08-15 Sanofi Aventis Sa Derives de pyrido-pyrimidone, leur preparation, leur application en therapeutique.
AU2007253513B2 (en) * 2006-05-23 2010-07-08 F. Hoffmann-La Roche Ag Pyridopyrimidinone derivatives
WO2008008704A2 (en) * 2006-07-11 2008-01-17 University Of Texas Health Science Center Inhibitors of cyclic nucleotide synthesis and their use for therapy of various diseases
US7474231B2 (en) * 2006-07-12 2009-01-06 Alcatel-Lucent Usa Inc. Radio communications for vehicle speed adjustment
UY33535A (es) * 2010-08-13 2011-12-01 Biolab Sanus Farmaceutuca Limitada Derivados de 6,7-dihidro-3h-oxazolo[3,4]pirazin-5,8-diona
US20150152101A1 (en) * 2012-06-06 2015-06-04 L'oreal Active compounds for combating greasy skin

Also Published As

Publication number Publication date
JP6661606B2 (ja) 2020-03-11
IL250968A0 (en) 2017-04-30
US20190218216A1 (en) 2019-07-18
BR112017004919A2 (pt) 2017-12-12
ES2701273T3 (es) 2019-02-21
CN107074847A (zh) 2017-08-18
EP3191099A2 (en) 2017-07-19
AU2015316120A1 (en) 2017-01-12
CA2958331A1 (en) 2016-03-17
CN114751905A (zh) 2022-07-15
CL2017000582A1 (es) 2017-11-24
CO2017001709A2 (es) 2017-03-31
HUE040387T2 (hu) 2019-03-28
US10822333B2 (en) 2020-11-03
US20160075702A1 (en) 2016-03-17
US10280162B2 (en) 2019-05-07
CA2958331C (en) 2019-12-17
PT3191099T (pt) 2018-12-18
AR101813A1 (es) 2017-01-11
AU2015316120B2 (en) 2018-05-17
WO2016037255A2 (en) 2016-03-17
WO2016037255A3 (en) 2016-06-30
MX2017003067A (es) 2017-06-14
IL250968B (en) 2020-03-31
KR20170054408A (ko) 2017-05-17
JP2017526666A (ja) 2017-09-14
EP3191099B1 (en) 2018-11-14
US20180111926A2 (en) 2018-04-26

Similar Documents

Publication Publication Date Title
SG11201706729SA (en) Derivatives of sobetirome
IL250089A0 (en) Metrology of multiple sampling processes
IL250328A0 (en) Polymorphs of selinxor
SI3154526T1 (sl) Trdne oblike sofosbuvira
HUE056357T2 (hu) Szobetirom származékok
SG11201609205WA (en) Heterocyclyl-butanamide derivatives
GB201416346D0 (en) Spirocyclic derivatives
PL3164393T3 (pl) Pochodne flawaglin
HUE050450T2 (hu) Fluoralkil-fluorén-származékok
GB201416352D0 (en) Spirocyclic derivatives
EP3186664C0 (en) ACCELERATION MEASUREMENT
PT3113773T (pt) Formas cristalinas do grapiprant
IL248773A0 (en) History of naphthyridinedione
IL246979A0 (en) Crystalline forms of sofosbuvir
AU361421S (en) Thermometers
AP2016009530A0 (en) Cycloalkyl-linked diheterocycle derivatives
HUE044703T2 (hu) Új CYP-eikozanoid származékok
PL3119744T3 (pl) Pochodne 2-cyjano-3-cyklopropylo-3-hydroksy-N-arylo-tioakryloamidu
IL249130B (en) Preparation of piperidine-4-carbothioamide
SG11201605072VA (en) Azaindole derivative
HUE040387T2 (hu) Piridopirimidin-származékok
IL249332A0 (en) Crystalline forms of sofosbuvir
HUP1400294A2 (hu) Clopidogrel új alkalmazása
PT3165222T (pt) Utilização do composto de ftalida
GB201404705D0 (en) Theory of Conceptual art